Prevalence and Factors Affecting Metabolic Syndrome in Burmese Type 2 Diabetic Patients in Thailand: A Single-Center, Cross-Sectional Study
Article Sidebar
Main Article Content
Abstract
Nowadays, the prevalence of metabolic syndrome (MetS) is increasing worldwide, and it was also found among type 2 diabetic patients. The objective of this study was to investigate the prevalence and factors affecting MetS in Burmese type 2 diabetic patients by using two different MetS criteria. In this cross-sectional study, information on general characteristics, anthropometry, laboratory parameters, and dietary intake was collected from Burmese patients with type 2 diabetes at Samutsakhon Hospital, Samut Sakhon Province, Thailand. The prevalence and factors affecting MetS were determined. The prevalence of MetS was 78.1% and 67.2% according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the International Diabetes Federation (IDF) criteria, respectively. According to the NCEP ATP III criteria, comorbid diseases (AOR: 3.96, 95%CI: 1.75-8.94) and time spent sitting >3 hours on a typical day (AOR: 5.40, 95%CI: 1.66-17.62) affected MetS. Based on the IDF criteria, the factors influencing MetS were female (AOR: 3.06, 95%CI: 1.31-7.19), comorbid diseases (AOR: 2.62, 95%CI: 1.27-5.41) and time spent sitting >3 hours on a typical day (AOR: 3.83, 95%CI: 1.29-11.35). Participants with MetS consumed more energy and all macronutrients than those without MetS (all p<0.05). The results of this study indicate the high prevalence of MetS in Burmese type 2 diabetic patients. Several factors affect MetS and these should be taken into consideration to develop strategies for prevention and management of MetS and type 2 diabetes in these patients.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.
References
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(suppl 1):S37-S42.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.
Tabish SA. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci. 2007;1(2):V-VIII.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6):231-237.
El Bilbeisi AH, Hosseini S, Djafarian K. Prevalence of metabolic syndrome and its components using two proposed criteria among patients with type 2 diabetes in Gaza Strip, Palestine. BAOJ Nutri. 2018;4(2):054.
Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924.
Nestel P, Lyu R, Low LP, Sheu WH-H, Nitiyanant W, Saito I, et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr. 2007;16(2): 362-367.
Maw SS. Prevalence of metabolic syndrome, its risk factors and associated lifestyles in Myanmar adult people: a community based cross-sectional study. Metabol Open. 2021; 12:100135.
Htwe TN, Oo MM, Hmon SW, Htun MM, Thein OM, Thandar M. Insulin receptor substrate-1 gene (G972R) polymorphism and metabolic syndrome in type 2 diabetes mellitus patients. MHSRJ. 2018; 30(1):21-25.
Betteridge DJ. The interplay of cardiovascular risk factors in the metabolic syndrome and type 2 diabetes. Eur Heart J Suppl. 2004;6(suppl_G): G3-G7.
Nsiah K, Shang VO, Boateng KA, Mensah F. Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. Int J Appl Basic Med Res. 2015;5(2):133-138.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735-2752.
Asadi Z, Shafiee M, Sadabadi F, Saberi-Karimian M, Darroudi S, Tayefi M, et al. Association between dietary patterns and the risk of metabolic syndrome among Iranian population: a cross-sectional study. Diabetes Metab Syndr. 2019;13(1):858-865.
Ueno S, Aung MN, Yuasa M, Ishtiaq A, Khin ET, Latt TS, et al. Association between dietary habits and type 2 diabetes mellitus in yangon, myanmar: a case–control study. Int J Environ Health Res Public Health. 2021;18(21):11056.
Aye TT, Aung MW, Oo ES. Diabetes mellitus in Myanmar: Socio-cultural challenges and strength. J Soc Health Diabetes. 2014;2(1): 9-13.
United Nations Thematic Working Group on Migration in Thailand. Thailand migration report 2019 [Internet]. 2019 [cited 2023 Apr 9]. Available from: https://thailand.un.org/sites/de
fault/files/2020-06/Thailand-Migration-Report-2019.pdf
Sarapirom K, Muensakda P, Sriwanna T. Lifestyles of Myanmar migrant workers under Thai socio-cultural context: a challenge of state management in the future. IRR. 2020;15(5):8-15.
Howteerakul N, Suwannapong N, Than M. Cigarette, alcohol use and physical activity among Myanmar youth workers, Samut Sakhon Province, Thailand. Southeast Asian J Trop Med Public Health. 2005;36(3):790-796.
Aung TNN, Shirayama Y, Moolphate S, Aung MN, Lorga T, Yuasa M. Health risk behaviors, musculoskeletal disorders and associated cultural adaptation, depression: a survey among Myanmar migrant workers in Chiangmai, Northern Thailand. Int J Gen Med. 2019;12:283-292.
Poe NED, Srichan P, Khunthason S, Apidechkul T, Suttana W. Prevalence and factors associated with hyperglycemia among Myanmar migrant workers in Mueang District, Chiang Rai Province, Thailand: a cross-sectional study.
J Health Sci Med Res. 2023;41(1):e2022882.
Memon MA, Ting H, Cheah JH, Thurasamy R, Chuah F, Cham TH. Sample size for survey research: review and recommendations. J Appl Struct Equ Model. 2020;4(2):i-xx.
Nam JY, Kim J, Cho KH, Choi Y, Choi J, Shin J, et al. Associations of sitting time and occupation with metabolic syndrome in South Korean adults: a cross-sectional study. BMC Public Health. 2016;16(1):943.
Janghorbani M, Amini M. Metabolic syndrome in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Metab Syndr Relat Disord. 2007;5(3):243-254.
Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. The Lancet. 2005;366(9491):1059-1062.
Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Ather Thromb. 2005;12(6):295-300.
Saif-Ali R, Kamaruddin NA, Al-Habori M, Al-Dubai SA, Ngah WZW. Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes. Diabetol Metab Syndr. 2020;12:67.
Herath H, Weerasinghe N, Weerarathna T, Amarathunga A. A comparison of the prevalence of the metabolic syndrome among Sri Lankan patients with type 2 diabetes mellitus using WHO, NCEP-ATP III, and IDF definitions. Int J Chronic Dis. 2018;2018:7813537.
Kittiskulnam P, Thokanit NS, Katavetin P, Susanthitaphong P, Srisawat N, Praditpornsilpa K, et al. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study. PLoS One. 2018;13(5):e0196332.
Biadgo B, Melak T, Ambachew S, Baynes HW, Limenih MA, Jaleta KN, et al. The prevalence of metabolic syndrome and its components among type 2 diabetes mellitus patients at a tertiary hospital, northwest Ethiopia. Ethiop J Health Sci. 2018;28(5):645-654.
Vasanthakumar J, Kambar S. Prevalence of obesity among type 2 diabetes mellitus patients in urban areas of Belagavi. Indian J Health Sci Biomed Res. 2020;13(1):21-27.
Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49
(4):403-414.
Litwin M, Kułaga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol. 2021;36(4):825-837.
Cohen JB, Cohen DL. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome. Curr Hypertens Rep. 2015;
(5):34.
Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014;7:
-591.
American Association of Diabetes Educators. Diabetes and physical activity. Diabetes Educ. 2012;38(1):129-132.
Lee O, Lee DC, Lee S, Kim YS. Associations between physical activity and obesity defined by waist-to-height ratio and body mass index in the Korean population. PLoS One. 2016;11(7):
e0158245.
Li Y, Zhao L, Yu D, Wang Z, Ding G. Metabolic syndrome prevalence and its risk factors among adults in China: a nationally representative cross-sectional study. PLoS One. 2018;13(6):
e0199293.
James M, Varghese TP, Sharma R, Chand S. Association between metabolic syndrome and diabetes mellitus according to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III criteria: a cross-sectional study. J Diabetes Metab Disord. 2020;19(1):437-443.
Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition. 2005;21(9):969-976.
Feng RN, Zhao C, Wang C, Niu YC, Li K, Guo FC, et al. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults. J Epidemiol. 2012;22(4):317-323.
James M, Mateti UV, Sharma R, Varghese TP, Chand S, Raju BN. Metabolic syndrome in Type II diabetes mellitus patients: anthropometric estimation and risk factors. Plant Arch. 2020;20
(2):7334-7338.
De Feo M, Del Pinto R, Pagliacci S, Grassi D, Ferri C. Real-world hypertension prevalence, awareness, treatment, and control in adult diabetic individuals: an Italian nationwide epidemiological survey. High Blood Press Cardiovasc Prev. 2021;28(3):301-307.
Aung TNN, Shirayama Y, Moolphate S, Lorga T, Jamnongprasatporn W, Yuasa M, et al. Prevalence and risk factors for hypertension among Myanmar migrant workers in Thailand. Int J Environ Res Public Health. 2022;19(6):3511.
Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Am J Med. 2009;122(6 Suppl):S37-S50.
Seravalle G, Grassi G. Sympathetic nervous system, hypertension, obesity and metabolic syndrome. High Blood Press Cardiovasc Prev. 2016;23(3):175-179.
Windler E. What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome? Atheroscler Suppl. 2005;6(3):11-14.
Liu J, Grundy SM, Wang W, Smith Jr SC, Vega GL, Wu Z, et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007;153
(4):552-558.
Diabetes Association of Thailand, The Endocrine Society of Thailand, Department of Medical Services, National Health Security Office. Clinical practice guideline for diabetes 2017 [Internet]. 2017 [cited 2023 Apr 9]. Available from: https://www.dmthai.org/new/index.php/sara-khwam-ru/bukhlakr-thangkar-phaethy/cpg/ guideline-diabetes-care-2017
Aekplakorn W, Satheannoppakao W, Putwatana P, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, et al. Dietary pattern and metabolic syndrome in Thai adults. J Nutr Metab. 2015;2015:468759.
Wang L, Wang H, Zhang B, Popkin BM, Du S. Elevated fat intake increases body weight and the risk of overweight and obesity among Chinese adults: 1991-2015 trends. Nutrients. 2020;12(11):3272.
Chupeerach C, Cho EM, Suttisansanee U, Chamchan R, Khemthong C, On-nom N. Reducing calories, fat, saturated fat and sodium in Myanmar recipes: effect on consumer acceptance. NFS Journal. 2021;25:51-55.
Bureau of Nutrition, Department of Health, Ministry of Public Health. Dietary reference intake for Thais 2020 [Internet]. 2020 [cited 2023 Apr 18]. Available from: https://www. thaidietetics.org/wp-content/uploads/2020/04/ dri2563.pdf
Jamshidi A, Farjam M, Ekramzadeh M, Homayounfar R. Evaluating type and amount of dietary protein in relation to metabolic syndrome among Iranian adults: cross-sectional analysis of Fasa Persian cohort study. Diabetol Metab Syndr. 2022;14(1):42.